Optimize HIV Prevention/Treatment
Building on Needle Exchange to Optimize HIV Prevention/Treatment
Biomedical interventions that have direct applicability to people who inject drugs (PWID) have flourished over the past 15 years. However, penetration of these interventions among PWID is low. Syringe service programs (SSP) are an essential risk reduction service for PWID, and represent the outermost reach of public health services for this population. The Baltimore City Health Department (BCHD) and investigators at Johns Hopkins University are developing a dedicated integrated care van (ICV) to complement the city’s mobile SSP with the goals of optimizing HIV care in HIV-positive clients and extending needed biomedical interventions to PWID.
Using a cluster-randomized trial design, this project aims to:
1) Determine whether the ICV intervention advances the HIV care cascade among HIV-positive PWID, improves the PrEP continuum, and increases uptake of MAT and HCV treatment.
2) Examine the implementation of the ICV intervention using a mixed methods approach among PWID, local/state public health stakeholders, and medical providers to examine the intervention's feasibility, acceptability, coverage, fidelity, and sustainability.
3) Determine the incremental cost-effectiveness of the ICV intervention.
|Page, Kathleen MD||National Institutes of Health|
||Project Start Date
|Department of Infectious Diseases, Johns Hopkins University School of Medicine||9/15/2017|
|Co - Principal Investigator
||Project End Date
|Lucas, Greg MD PhD||7/31/2022|
|Other Co - Principal Investigators